期刊文献+

深化药物性肝病的临床和基础研究 被引量:12

原文传递
导出
摘要 药物性肝病又称药物性肝损伤(drug induced liver injury,DILI),是常见的肝病之一,其发病率仅次于病毒性肝炎、脂肪性肝病(酒精和非酒精性),但由于临床表现不明显或被原发病掩盖,以及缺乏特异性诊断方法,因而常被忽视或误诊。各种中、西医师,特别是广大的非内科医师或基层全科医师对DILI认知度很低,误诊率更高。
作者 姚光弼
出处 《中华消化杂志》 CAS CSCD 北大核心 2007年第7期433-434,共2页 Chinese Journal of Digestion
  • 相关文献

参考文献6

  • 1Nathwani RA, Kaplowitz N. Drug hepatotoxieity. Clin Liver Dis, 2006, 10:207-217, vii.
  • 2Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology, 2002, 36:451-455.
  • 3Meier Y, Cavallaro M, Roos M, et al. Incidence of drug- induced liver injury in medical inpatients. Eur J Clin Pharmacol, 2005, 61:135-143.
  • 4Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology, 2006, 43: 618-631.
  • 5Danan G, Benichou C. Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46 : 1323-1330.
  • 6Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997, 26:664-669.

同被引文献152

引证文献12

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部